Hanway Associates is an advisory firm specialising in strategy, research, and M&A for the cannabis sector.
Hanway works to open new cannabis markets, and helps companies launch, build and grow within them.
We provide advisory services to cannabis, agricultural and FMCG companies, sophisticated investors and innovative startups looking to understand and operate in the sector.
We specialise in bringing clarity to the most complex issues shaping the future of the cannabis sector.
We do this by building first-of-a-kind reports backed by interviews, new data and public polling. We focus stakeholders and create momentum around these important issues.
We launch these reports through our publishing arm, First Wednesdays.
Recreational Europe (April 2022)
Recreational Europe explores the theory that Europe’s trajectory compares to the US in 2012 when Washington and Colorado legalised – and the early signs of the ‘domino effect’.
European Investment Ecosystem (July 2021)
The European Cannabis Investment Ecosystem (ECIE) examines the scope and scale of major, EU-wide investments by venture capitalists and retail investors, and documents major corporates and institutional investors that are beginning to dip their toes into the sector – reversing the flow of capital across the Atlantic.
European Medical Ecosystem (June 2020)
The European Medical Ecosystem report is produced in collaboration with Invest in Denmark, part of the Danish Ministry of Foreign Affairs. The report highlights key players and emerging trends in Europe's unique medical cannabis ecosystem, with insight into how the market has formed and how it looks set to evolve.
Key Hanway achievements
→ Part of the team that legalised medical cannabis in the UK
→ Co-founded Cannabis Europa conference
→ Incubated multiple cannabis startups
→ Won first cultivation licence on British Isles since GW
→ Won 1 of 10 Dutch recreational licences for clients
